CM
SLNO

Caption Management’s Soleno Therapeutics SLNO Stock Holding History

Caption Management’s Portfolio SLNO Stock Details SLNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$39.1M Buy
1,169,200
+826,700
+241% +$32.4M 0.23% 92
2025
Q4 		$15.9M Sell
342,500
-673,600
-66% -$36.9M 0.11% 226
2025
Q3 		$68.7M Buy
1,016,100
+450,300
+80% +$33.4M 0.54% 28
2025
Q2 		$47.4M Buy
565,800
+393,700
+229% +$29.5M 0.52% 26
2025
Q1 		$12.3M Sell
172,100
-266,400
-61% -$13M 0.12% 157
2024
Q4 		$19.7M Buy
438,500
+437,500
+43,750% +$22.7M 0.19% 83
2024
Q3 		$50.5K Sell
1,000
-214,200
-100% -$10.3M ﹤0.01% 1163
2024
Q2 		$8.78M Buy
215,200
+155,200
+259% +$6.58M 0.14% 163
2024
Q1 		$2.57M Buy
60,000
+40,000
+200% +$1.81M 0.04% 463
2023
Q4 		$805K Buy
+20,000
New +$569K 0.01% 857

Other funds holding SLNO

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
KCM
Khrom Capital Management Miami Beach, Florida $1.09B AUM 14.82% 1-Year Est. Return

Caption Management's SLNO Position: Q1 2026 in Review

Caption Management increased its Soleno Therapeutics (SLNO) stake by 898% in Q1 2026, buying an estimated $14.8M and bringing the position to 420,143 shares worth $14.1M. The position accounts for 0.08% of the portfolio, ranked #262.

Caption Management first reported a position in SLNO in Q1 2024 and has held it in 9 quarters since. The position peaked at $25M in Q3 2025. 225 funds tracked by Wall St. Rank hold SLNO as of Q1 2026.

  • Caption Management held 420,143 shares of Soleno Therapeutics worth $14.1M as of Q1 2026.
  • Caption Management bought 378,043 Soleno Therapeutics shares in Q1 2026, an estimated $14.8M.
  • Soleno Therapeutics made up 0.08% of Caption Management's portfolio in Q1 2026, its #262 holding.
  • Caption Management first reported a position in Soleno Therapeutics in Q1 2024 and has held it in 9 quarters since.
  • Caption Management's Soleno Therapeutics position peaked at $25M in Q3 2025.
  • 225 funds tracked by Wall St. Rank held Soleno Therapeutics as of Q1 2026.

Based on Caption Management's 13F filing for Q1 2026, filed 15 May 2026.